NEPARVIS 49 MG/51 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
NEPARVIS 49 MG/51 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
161103003IP
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Nov 15, 2022
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number161103003IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
SACUBITRILOActive
Quantity: 48,6 mg
Name: SACUBITRILO
VALSARTANActive
Quantity: 51,4 mg
Name: VALSARTAN
ATC CLASSIFICATION (3)
C09D
C09DX
C09DX04